Actavis Acquiring Warner Chilcott For $8.5 BillionMani
Actavis Inc (NYSE:ACT) today announced its definitive agreement to acquire Warner Chilcott plc (NASDAQ:WCRX) in an all stock transaction valued at approximately $8.5 billion.
Actavis, Warner Chilcott Deal:
The generic drug maker Actavis Inc (NYSE:ACT) is to acquire the specialty pharmaceutical company Warner Chilcott.
The deal means that Warner Chilcott shareholders to receive 0.16 shares of Actavis for each Warner Chilcott . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.